Jump Financial, LLC Ginkgo Bioworks Holdings, Inc. Transaction History

Jump Financial, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$1.06 - $1.67 $309,944 - $488,308	292,400 Added 1405.77%	313,200 $363,000
Q4 2023 Oct 21, 2024	SELL	$1.26 - $1.79 $99,792 - $141,768	-79,200 Reduced 79.2%	20,800 $35,000
Q4 2023 Feb 07, 2024	SELL	$1.26 - $1.79 $99,792 - $141,768	-79,200 Reduced 79.2%	20,800 $35,000
Q3 2023 Oct 21, 2024	BUY	$1.61 - $2.54 $96,992 - $153,019	60,244 Added 151.53%	100,000 $181,000
Q3 2023 Nov 07, 2023	BUY	$1.61 - $2.54 $96,992 - $153,019	60,244 Added 151.53%	100,000 $181,000
Q2 2023 Oct 21, 2024	SELL	$1.14 - $1.95 $168,290 - $287,864	-147,623 Reduced 78.78%	39,756 $73,000
Q2 2023 Aug 07, 2023	SELL	$1.14 - $1.95 $168,290 - $287,864	-147,623 Reduced 78.78%	39,756 $73,000
Q1 2023 Oct 21, 2024	BUY	$1.2 - $2.19 $224,854 - $410,360	187,379 New	187,379 $249,000
Q1 2023 May 03, 2023	BUY	$1.2 - $2.19 $224,854 - $410,360	187,379 New	187,379 $249,000
Q3 2022 Nov 07, 2022	SELL	$0.73 - $3.74 $14,308 - $73,307	-19,601 Reduced 64.69%	10,699 $33,000
Q2 2022 Aug 09, 2022	BUY	$2.2 - $4.2 $66,660 - $127,260	30,300 New	30,300 $72,000

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $12.1B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.